Alpha 2.0
Login Register
» Articles » PMID: 28114637

High Prices for Drugs With Generic Alternatives: The Curious Case of Duexis

Overview
Journal JAMA Intern Med
Publisher American Medical Association
Specialty General Medicine
Date 2017 Jan 24
PMID 28114637
Citations 7
Authors
Aaron Hakim
Joseph S Ross
Affiliations
Soon will be listed here.
Citing Articles

Identifying drugs with the greatest increases and decreases in spending per beneficiary using Medicare Part D: A cross-sectional study.

Hodzic-Santor B, Sacks C, Van Bakel T, Fralick M PLoS One. 2023; 18(2):e0281076.

PMID: 36758003 PMC: 9910683. DOI: 10.1371/journal.pone.0281076.

Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021.

Gupta R, Morten C, Zhu A, Ramachandran R, Shah N, Ross J JAMA Health Forum. 2022; 3(5):e221096.

PMID: 35977259 PMC: 9123500. DOI: 10.1001/jamahealthforum.2022.1096.

Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists.

Volerman A, Pelczar A, Conti R, Ciaccio C, Chua K BMC Health Serv Res. 2022; 22(1):562.

PMID: 35473608 PMC: 9044602. DOI: 10.1186/s12913-022-07955-x.

Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.

Sacks C, Lee C, Kesselheim A, Avorn J JAMA. 2018; 320(7):650-656.

PMID: 30140875 PMC: 6142946. DOI: 10.1001/jama.2018.11439.

A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses.

Levy J, Rosenberg M, Vanness D Value Health. 2018; 21(6):677-684.

PMID: 29909872 PMC: 6394851. DOI: 10.1016/j.jval.2017.06.013.